KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $90.0 billion.

  • Bristol Myers Squibb's Liabilities and Shareholders Equity fell 276.99% to $90.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $374.0 billion, marking a year-over-year decrease of 155.81%. This contributed to the annual value of $90.0 billion for FY2025, which is 276.99% down from last year.
  • Bristol Myers Squibb's Liabilities and Shareholders Equity amounted to $90.0 billion in Q4 2025, which was down 276.99% from $96.9 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Liabilities and Shareholders Equity peaked at $112.4 billion during Q1 2021, and registered a low of $90.0 billion during Q4 2025.
  • Its 5-year average for Liabilities and Shareholders Equity is $98.5 billion, with a median of $96.0 billion in 2022.
  • Per our database at Business Quant, Bristol Myers Squibb's Liabilities and Shareholders Equity plummeted by 1349.12% in 2021 and then surged by 503.81% in 2024.
  • Bristol Myers Squibb's Liabilities and Shareholders Equity (Quarter) stood at $109.3 billion in 2021, then dropped by 11.43% to $96.8 billion in 2022, then dropped by 1.72% to $95.2 billion in 2023, then dropped by 2.69% to $92.6 billion in 2024, then fell by 2.77% to $90.0 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $90.0 billion for Q4 2025, versus $96.9 billion for Q3 2025 and $94.7 billion for Q2 2025.